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INTRODUCTION
Ischemia-reperfusion injury (IRI) is of clinical importance
in many clinical situations. Reperfused tissue after ischemia
shows additional reperfusion injury, which is related to the
duration of the ischemia and the tissue susceptibility. While
ischemia injury stems from a deficiency of energy necessary
to maintain homeostasis, reperfusion injury is thought to be
primarily due to attacks by generated oxygen radicals. During
reperfusion, hypoxanthine, which has been accumulated dur-
ing ischemia, is metabolized to xanthine by xanthine oxidase.
In this process superoxide radical ( ∙O2-) is generated and
converted to hydrogen peroxide (H2O2) or a hydroxyl radical
(OH ∙) (1).
The endogenous antioxidant mechanism includes superox-
ide dismutase (SOD), selenium-dependent glutathione per-
oxidase, and catalase (1, 2). Exogenous antioxidants such as
vitamin E, vitamin C,  -carotene, urate, albumin, and biliru-
bin can also scavenge potent radicals (3). Vascular endothelial
injury plays an important role in the early stage of IRI (4, 5).
Nitric oxide (NO) is essential to vascular homeostasis (6), and
the failure of NO production from endothelial cells has been
shown to be the primary mechanism of microvascular failure
in IRI (7, 8). There are some data showing that NO supple-
mentation in IRI reduces the extent of IRI and protects tis-
sues from IRI (8-11).
The effect of antioxidant therapy and NO supplement on
hepatic IRI has not yet been completely elucidated. This ex-
periment was designed to evaluate the effects of antioxidants
and NO supplement on hepatic IRI in rats.
MATERIALS AND METHODS
Experimental animals & porto-systemic shunt opera-
tion
Male rats of the Sprague-Dowley strain weighing 100 to
150 g were used. All rats were treated in accordance with
the Guide for the Care and Use of Laboratory Animals (NIH
Publication No. 86-23, revised 1985). All surgical procedures
were performed under the anesthesia of intraperitoneal ke-
tamine injection (50 mg/kg). Four weeks before the portal
clamping procedure, all rats had undergone porto-systemic
shunt operations for the purpose of minimizing splanchnic
vascular congestion and mesenteric venous thrombosis dur-
ing portal clamping. The procedures consisted of artificial hernia
formation of the cecum into the subcutaneous space between
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The Effects of Antioxidants and Nitric Oxide Modulators on Hepatic
Ischemic-Reperfusion Injury in Rats
Ischemic-reperfusion injury (IRI) is thought to be caused by oxygen radicals. Nitric
oxide (NO) also has been thought to play a key role in IRI. This experiment was
designed to evaluate the effects of antioxidants and NO supplement on hepatic
IRI. Male Sprague-Dawley rats were divided into five groups: a sham operation
group, a group with IRI, and three groups with vitamin C combined with vitamin
E (VC&VE), L-arginine and N
G-nitro-L-arginine (NNLA) injected after IRI. IRI was
induced by clamping of the porta hepatis for 30 minutes and then by declamping.
To prevent mesenteric blood congestion, a porto-systemic shunt had been made
four weeks before the portal clamping. Biochemical assays of TNF- level and
NO2- level in the blood, malondialdehyde level, catalase activity and NO synthase
activity in the liver tissue were performed. The results were as follows: IRI increased
the malondialdehyde level and exhausted the catalase activity remarkably. VC&VE
lowered the malondialdehyde levels and protected against catalase exhaustion,
but had no significant effect on the NO production. L-arginine had a definite antiox-
idant effect, which was much weaker than that of VC&VE. In conclusion, antioxi-
dants and a supplement of NO protected the liver tissue against IRI.
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Accepted : 29 March 2002the muscle layer and the subcutaneous fat layer. All rats sur-
vived 30 min of portal clamping due to the capillary anasto-
mosis between the cecal mesentery and the muscle layer.
Ischemia-reperfusion injury (IRI) induction
During the entire period of IRI, the rats were placed on a
thermo-regulated operation table (37℃) to maintain a con-
stant body temperature.
The method of IRI induction was as follows: following la-
parotomy, the liver was made ischemic by portal triad occlusion
with a small Bulldog vascular clamp for 30 min followed by
reperfusion.
The rats were divided into five groups; a sham operation
(SO) group, a ischemia-reperfusion (IR) group, a antioxidant
(IRCE) group, a L-arginine (IRA) group, and a NG-nitro-L-
arginine (IRNA) group.
The SO group received a sham operation which was com-
posed of shaving, laparotomy incision, keeping the incision
open for 30 min without IRI induction, and closure of the
incision. The IR group was given IRI induction with no drug
administration. The IRCE group received 100 mg vitamin
E ( -Tocopherol, Sigma, St Louis, MO, U.S.A.) orally 24 hr
before IRI induction, an intraperitoneal injection of vitamin C
(L-ascorbic acid, Sigma) at a dose of 100 mg/kg, IRI induction,
and then intraperitoneal injections of vitamin C at a dose of
100 mg/kg hourly following IRI induction. The IRA group
received an intraperitoneal injection of L-arginine (Sigma) at a
dose of 100 mg/kg 20 min before IRI induction, and then IRI
induction, and intraperitoneal injections of L-arginine at a
dose of 50 mg/kg hourly. The IRNA group received an in-
traperitoneal injection of NG- nitro-L-arginine (Calbiochem,
Darmstadt, Germany) at a dose of 30 mg/kg 20 min before
IRI induction, and then IRI induction, and intraperitoneal in-
jections of NG-nitro-L-arginine at a dose of 30 mg/kg hourly.
Five rats in each group were sacrificed at post-reperfusion 1 hr
and 6 hr.
Sampling was done as follows: through a long midline inci-
sion from the chest to abdomen, the right atrium was punc-
tured and blood was aspirated with a heparin-coated syringe.
Following blood sampling, the liver was resected promptly
and stored at -70℃. The blood was centrifuged, and the serum
was stored at -70℃.
Biochemical assays
Blood TNF- level was measured with the sandwich en-
zyme immunoassay using a solid-phase ELISA kit (Biosource,
Camarillo, CA, U.S.A.). The absorbance of each well was
measured by ELISA reader (CERES UV900HDi, Bio-Tek
Instruments, Winooski, VT, U.S.A.) at 450 nm. The detec-
tion limit of the TNF- measurement was 4 pg/mL.
The malondialdehyde (MDA) in liver tissue was measured
with the Ohkawa’ s method (1979) using thiobarbituric
acid (Sigma) reaction (12, 13). Absorbance at 532 nm was
measured by spectrophotometer (DU 650, Beckman). The
unit of measurement was nmol/g of liver tissue.
Catalase activity in the liver tissue was measured with the
Beers & Sizer’ s method (1952) (14). Absorbance at 240 nm
was measured by spectrophotometer. The unit of measurement
was units/mg of liver tissue.
Nitric oxide amount that had been produced was measured
as total sum of plasma nitrite (NO2-) and nitrate (NO3-) con-
centrations using the Griess reaction kit (15) (R&D Systems).
Nitrate was converted to nitrite by nitrate reductase. The sum
of converted nitrate concentrations plus intrinsic nitrite con-
centations were expressed as nitrite concentrations ( mol/L)
by optical absorbances with a spectrophotometer (CERES
UV900HDi) at 540 nm. Sodium nitrite solutions were used
as standards.
i-NOS activity in the liver tissue was measured as the con-
version rate of 3H-L-arginine (Amersham) to 3H-L-citrulline.
Because L-arginine is a cation, L-citrulline can be separated
from L-arginine by cation exchange resin. The number of  -
particles from 3H of produced 3H-L-citrulline was measured
by liquid scintillation spectrometer (TRI-CARB, Packard).
This was expressed as counts per min (cpm).
Measured values were expressed as the mean±standard de-
viation. Kruskal-Wallis test and Mann-Whitney test were
used to compare the means of each group using the SPSS for
Windows Release 10.0 package. A p-value below 0.05 was
considered statistically significant.
RESULTS
TNF- levels in the blood
The TNF- level of the normal rats was 12.74±6.03 pg/
mL (Fig. 1). The TNF- level of the IR group after 6 hr
reperfusion was significantly increased compared with that of
the SO group (p=0.001). The TNF- level of the IRCE
group after 6 hr re- perfusion was significantly decreased
compared with that of the IR group (p<0.0001). The
TNF- level of the IRA group after 6 hr was lower than that
of the IR group (p=0.004). The TNF- levels of the IRNA
group after 1 and 6 hr were lower than those of the IR group
(p=0.029 and p=0.126, respectively).
MDA levels in liver tissues
The MDA level of the normal rats was 143.46±26.68
nmol/g (Fig. 2). The MDA levels of the IR group after 1
and 6 hr were much higher than those of the SO group (p<
0.0001 for both comparisons). The MDA levels of the IRCE
group after 1 and 6 hr were significantly decreased compared
with those of the IR group (p<0.0001 for both comparisons).
The MDA levels of the IRA group were markedly reduced
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comparisons), although significantly higher than those of the
IRCE group (p<0.0001). The MDA levels of the IRNA group
were reduced when compared with those of the IR group (p=
0.001 and p=0.035, respectively), but significantly higher than
those of the IRA group (p<0.0001 and p=0.002, respectively).
Catalase activities in liver tissue
The catalase activity of normal rats was 1427.148±104.54
unit/mg (Fig. 3). The catalase activities of the IR group were
markedly decreased compared with those of the SO group
for both 1 hr and 6 hr reperfusion (p<0.0001 and p=
0.0001, respectively). The catalase activities of the IRCE
group after 1 and 6 hr were much higher than those of the
IR group (p<0.0001 and p=0.0001, respectively). The cata-
lase activities of the IRA group after 1 and 6 hr were signifi-
cantly higher than those of the IR group (p=0.003 and
p=0.001, respectively), but much lower than those of the
IRCE group (p<0.0001 and p=0.0001, respectively). The
catalase activities of IRNA group were not different from
those of the IR group (p=0.369 and p=0.882, respectively),
and lower than those of the IRA group (p=0.077 and
p=0.024, respectively).
Nitrite concentrations in serum
The nitrite concentration of normal rats was 10.84±2.08
unit/mg (Fig. 4). The nitrite concentration of the IR group
were markedly increased compared with those of the SO
group at 6 hr of reperfusion (p=0.009). The concentration
of the IRCE group was higher at 1 hr of reperfusion and
lower at 6 hr of reperfusion than those of the IR group, but
without statistical significance (p=0.175 and p=0.175,
respectively). The nitrite concentrations of the IRA group
after 1 and 6 hr were significantly higher than those of the
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Fig. 2. The effects of vitamin C/vitamin E, L-arginine, and N
G-
nitro-L-arginine on lipid peroxidation in rat liver tissues injured by
ischemic-reperfusion. SO: sham operation, IR: ischemia-reperfu-
sion, IRCE: ischemia-reperfusion with vitamin C and vitamin E,
IRA: ischemia-reperfusion with L-arginine, IRNA: ischemia-reper-
fusion with N
G-nitro-L-arginine.
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Fig. 3. The effects of vitamin C/vitamin E, L-arginine, and N
G-nitro-
L-arginine on catalase activities in rat liver tissue injured by ischemic-
reperfusion. SO: sham operation, IR: ischemia-reperfusion, IRCE:
ischemia-reperfusion with vitamin C and vitamin E, IRA: ischemia-
reperfusion with L-arginine, IRNA: ischemia-reperfusion with N
G-
nitro-L-arginine.
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Fig. 4. The effects of vitamin C/vitamin E, L-arginine, and N
G-nitro-
L-arginine on the blood nitrite and nitrate levels in ischemic-reper-
fusion injured rat. SO: sham operation, IR: ischemia-reperfusion,
IRCE: ischemia-reperfusion with vitamin C and vitamin E, IRA:
ischemia-reperfusion with L-arginine, IRNA: ischemia-reperfusion
with N
G-nitro-L-arginine.
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Fig. 1. The effects of vitamin C/vitamin E, L-arginine, and N
G-nitro-
L-arginine on the blood TNF- levels in ischemic-reperfusion injured
rats. SO: sham operation, IR: ischemia-reperfusion, IRCE: ischemia-
reperfusion with vitamin C and vitamin E, IRA: ischemia-reperfu-
sion with L-arginine, IRNA: ischemia-reperfusion with N
G-nitro-L-
arginine.
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LIR group (p=0.028 and p=0.047, respectively), and higher
than those of theIRCE group (p=0.117 and p=0.009, respec-
tively). The concentrations of the IRNA group were marked-
ly decreased compared with the IR group (p=0.016 and
p=0.009, respectively).
i-NOS activities in liver tissue
The activities of the IR group were lower at 1 hr of reper-
fusion and higher at 6 hr of reperfusion than those of the SO
group, but the difference were not statistically significant
(p=0.147 and p=0.061, respectively) (Fig. 5). The activities
of the IRCE group were higher than those of the IR group,
but the differences were not significant (p=0.113 and p=0.126,
respectively). The activity of the IRA group after 1 hr was high-
er than that of the IR group (p=0.044). The activities of the
IRNA group were lower than those of the IR group at 1 hr
and 6 hr of reperfusion (p=0.053 and p<0.0001, respectively).
DISCUSSION
The hepatic IRI model used in this study was portal triad
occlusion for 30 min with a subsequent reperfusion period of
60 and 360 min. Without porto-systemic shunt operation,
the mortality of rats was over 50% and severe mesenteric vas-
cular congestion and edema was observed in all surviving rats.
With this shunt operation, mesenteric vascular congestion was
markedly reduced and no rat died.
Vitamin C and vitamin E were used as antioxidants. Vitamin
C is known to participate in antioxidant action more rapidly
than bilirubin, urate, the sulfhydryl group and  -tocopherol,
and lipid peroxidation occurs after vitamin C has been depleted
(3). Vitamin C repairs vitamin E, thereby permitting vitamin
E to recycle (16). A high dose of vitamin C (14 mg/kg ∙hr) is
necessary to detoxify the large amount of oxygen radicals in
burn (17). The usual dosage is ineffective (18). This experi-
ment also used a high-dose of vitamin C. It was demonstrated
that a high-dose vitamin C with pre-treatment of vitamin E
was very effective in preventing catalase exhaustion and pro-
tecting against IRI in the liver. A few studies reported that
administration of antioxidants afforded complete protection
against IRI in various organs (5, 19-21).
TNF- is thought to play some role in IRI because it is high-
ly expressed in the transplanted liver regardless of rejection
(22). TNF- induces i-NOS, although it suppresses consti-
tutive NOS (23).
The TNF- level in the blood rather than TNF- gene ex-
pression was measured in this study. A greater increase of the
TNF- level after 6 hr of reperfusion rather than 1 hr may in-
dicate that TNF- does not play an important role in the very
early stage of hepatic IRI.
As an index of lipid peroxidation and oxidative tissue injury,
MDA is reliable (24). It has been demonstrated that the admin-
istration of L-arginine had some antioxidant effects in hepatic
IRI. NO acts as a signal to activate glutathione peroxidase and
increase reduced glutathione. Glutathione peroxidase and ca-
talase convert H2O2 to H2O and O2, and this may explain the
mechanism of reducing catalase exhaustion by administration
of L-arginine. If this is true, administration of NG-nitro-L-argi-
nine should show a negative antioxidant effect. However, the
same antioxidant effect as that of L-arginine was observed,
although the antioxidant effect of NG-nitro-L-arginine was
much weaker than that of L-arginine. Actually NO combines
with O2 ∙- to make ONOO ∙-, and this ONOO ∙- is known
to be more toxic than O2∙-. This may suggest another bi-di-
rectional action of NO.
Although many reports have demonstrated the protective
effect of NO supplement in IRI (8, 10, 11), a few reports
proposed that the blocking of NO synthesis gave protection
against IRI (5, 25). The result that NG-nitro-L-arginine had
a similar antioxidant effect as that of L-arginine was self-
contradictory and should be elucidated in further studies.
The NOS activity was depressed after 1 hr of reperfusion
but increased after 6 hr of reperfusion. This induction of i-
NOS was thought to be due to oxygen radicals and IL-1 ,
and to play a self-protective role against IRI (26). Reducing
the oxidative stimulus by administration of an antioxidant
would decrease i-NOS induction, but the i-NOS activity of
the IRCE group in this study was increased. The reason for
this result may be as follows. First, this study was an in vivo
experiment, and antioxidant therapy had a more profound
protective effect on the i-NOS system. Second, vitamin C
may be an inducing factor of i-NOS by itself.
The results of this study suggest the following points. First,
both antioxidants and a nitric oxide donor have definite pro-
tective effects on ischemia-reperfusion injury of the liver. Sec-
ond, the administration of antioxidants is a much more
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Fig. 5. The effect of vitamin C/vitamin E, L-arginine, and N
G-nitro-
L-arginine on NOS activity in rat liver tissue injured by ischemic-
reperfusion. SO: sham operation, IR: ischemia-reperfusion, IRCE:
ischemia-reperfusion with vitamin C and vitamin E, IRA: ischemia-
reperfusion with L-arginine, IRNA: ischemia-reperfusion with N
G-
nitro-L-arginine.
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meffective method of reducing ischemia-reperfusion injury than
the supplement with a NO donor. Further studies are neces-
sary to elucidate the mild antioxidant effect of blocking of
NO synthesis in hepatic ischemia-reperfusion injury.
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